Skip to main content
Clinical Trials/NCT03233607
NCT03233607CompletedNot Applicable

Optimal Time for Postpartum Hemoglobin Assessment and Its Correlation With Estimated Blood Loss (EBL)/Quantitative Blood Loss (QBL)

Columbia University1 site in 1 country100 target enrollmentStarted: March 20, 2018Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
100
Locations
1
Primary Endpoint
Correlation of maternal hemoglobin to EBL

Study Overview

Brief Summary

This is a prospective cohort study of patients delivering at Columbia University Medical Center/ Allen Hospital. For the primary research question, the investigators will compare the change in maternal hemoglobin from postpartum day 1 to day 2 and also determine correlation with estimation of blood loss (EBL) and quantitative blood loss (QBL).

Detailed Description

Postpartum hemorrhage is a leading cause of maternal mortality and morbidity worldwide. Early intervention is dependent on care providers ability to accurately estimate ongoing blood loss. Studies in the past have shown that obstetricians and midwives tend to overestimate blood loss when the lost volumes are small while tend to underestimate by as much as 40 to 50 percent when a large volume of blood is lost.

Multiple studies have shown that routine hemoglobin assessment in postpartum patients after uneventful delivery either vaginal or via cesarean section, is not necessary. This leads to increased cost of care without any added benefit and causes inconvenience to the patients. However knowing how imprecise blood loss estimation can be it is reasonable to screen women for anemia prior to discharge.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • All antepartum patients receiving prenatal care at the Broadway Practice and plan to deliver at Allen Hospital in NYC.

Exclusion Criteria

  • Patients who gave consent to participate in the study but did not deliver at Allen hospital.

Outcomes

Primary Outcomes

Correlation of maternal hemoglobin to EBL

Time Frame: Up to 2 days after delivery

Maternal hemoglobin will be measured to assess correlation to visually estimated blood loss

Correlation of maternal hemoglobin to QBL

Time Frame: Up to 2 days after delivery

Maternal hemoglobin will be measured to assess correlation to quantified blood loss

Change in maternal hemoglobin

Time Frame: Day 1 and Day 2

Maternal hemoglobin will be measured on postpartum day 1 to day 2

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Rachana Gavara

Assistant Professor of Obstetrics and Gynecology

Columbia University

Study Sites (1)

Loading locations...

Similar Trials